ZA200702869B - Mutated amyloid protein - Google Patents
Mutated amyloid proteinInfo
- Publication number
- ZA200702869B ZA200702869B ZA200702869A ZA200702869A ZA200702869B ZA 200702869 B ZA200702869 B ZA 200702869B ZA 200702869 A ZA200702869 A ZA 200702869A ZA 200702869 A ZA200702869 A ZA 200702869A ZA 200702869 B ZA200702869 B ZA 200702869B
- Authority
- ZA
- South Africa
- Prior art keywords
- amyloid protein
- mutated amyloid
- mutated
- protein
- amyloid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0007—Nervous system antigens; Prions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Neurology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biophysics (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- General Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Mycology (AREA)
- Pathology (AREA)
- Toxicology (AREA)
- Food Science & Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Wood Science & Technology (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004294292 | 2004-10-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200702869B true ZA200702869B (en) | 2008-07-30 |
Family
ID=36142786
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200702869A ZA200702869B (en) | 2004-10-06 | 2005-10-06 | Mutated amyloid protein |
Country Status (15)
Country | Link |
---|---|
US (1) | US20080063636A1 (fr) |
EP (1) | EP1811025A4 (fr) |
JP (1) | JP4776544B2 (fr) |
KR (1) | KR20070100234A (fr) |
CN (1) | CN101052718A (fr) |
AU (1) | AU2005290401A1 (fr) |
BR (1) | BRPI0516279A (fr) |
CA (1) | CA2583431A1 (fr) |
IL (1) | IL182404A0 (fr) |
MX (1) | MX2007004149A (fr) |
NO (1) | NO20072158L (fr) |
NZ (1) | NZ554794A (fr) |
RU (1) | RU2007116346A (fr) |
WO (1) | WO2006038729A1 (fr) |
ZA (1) | ZA200702869B (fr) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10303974A1 (de) | 2003-01-31 | 2004-08-05 | Abbott Gmbh & Co. Kg | Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung |
SG2014013437A (en) | 2005-11-30 | 2014-07-30 | Abbott Lab | Monoclonal antibodies and uses thereof |
RU2442793C2 (ru) | 2005-11-30 | 2012-02-20 | Эбботт Лэборетриз | АНТИТЕЛА ПРОТИВ ГЛОБУЛОМЕРА Аβ, ИХ АНТИГЕНСВЯЗЫВАЮЩИЕ ЧАСТИ, СООТВЕТСТВУЮЩИЕ ГИБРИДОМЫ, НУКЛЕИНОВЫЕ КИСЛОТЫ, ВЕКТОРЫ, КЛЕТКИ-ХОЗЯЕВА, СПОСОБЫ ПОЛУЧЕНИЯ УКАЗАННЫХ АНТИТЕЛ, КОМПОЗИЦИИ, СОДЕРЖАЩИЕ УКАЗАННЫЕ АНТИТЕЛА, ПРИМЕНЕНИЯ УКАЗАННЫХ АНТИТЕЛ И СПОСОБЫ ИСПОЛЬЗОВАНИЯ УКАЗАННЫХ АНТИТЕЛ |
US8455626B2 (en) | 2006-11-30 | 2013-06-04 | Abbott Laboratories | Aβ conformer selective anti-aβ globulomer monoclonal antibodies |
US20100311767A1 (en) | 2007-02-27 | 2010-12-09 | Abbott Gmbh & Co. Kg | Method for the treatment of amyloidoses |
MX360403B (es) | 2010-04-15 | 2018-10-31 | Abbvie Inc | Proteinas de union a amiloide beta. |
JP6147665B2 (ja) | 2010-08-14 | 2017-06-14 | アッヴィ・インコーポレイテッド | アミロイドベータ結合タンパク質 |
JP6323876B2 (ja) * | 2013-02-14 | 2018-05-16 | 公立大学法人大阪市立大学 | ノックインマウス |
CA3220267A1 (fr) | 2021-05-26 | 2022-12-01 | Kariem Ezzat Ahmed | Compositions et procedes pour le traitement et/ou la prophylaxie de proteinopathies |
WO2024071361A1 (fr) * | 2022-09-27 | 2024-04-04 | 株式会社カネカ | Méthode d'évaluation d'activité d'inhibition ou de promotion de coagulation contre une protéine coagulante |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5338663A (en) * | 1990-08-24 | 1994-08-16 | President And Fellows Of Harvard College | Method of identifying inhibitors of β-protein esterase activity |
ATE286072T1 (de) * | 2000-05-22 | 2005-01-15 | Univ New York | Synthetische immunogene jedoch nicht amyloidogene peptide, die homolog zu amyloid beta sind und deren verwendung zur induktion einer immunantwort gegen amyloid beta und amyloidaggregate |
US7479482B2 (en) * | 2001-11-21 | 2009-01-20 | New York University | Synthetic immunogenic but non-deposit-forming polypeptides and peptides homologous to amyloid β, prion protein, amylin, α-synuclein, or polyglutamine repeats for induction of an immune response thereto |
US20040091945A1 (en) * | 2002-07-17 | 2004-05-13 | Cheryl Fitzer-Attas | Peptides and methods of screening immunogenic peptide vaccines against Alzheimer's Disease |
-
2005
- 2005-10-06 BR BRPI0516279-3A patent/BRPI0516279A/pt not_active IP Right Cessation
- 2005-10-06 US US11/664,714 patent/US20080063636A1/en not_active Abandoned
- 2005-10-06 NZ NZ554794A patent/NZ554794A/en unknown
- 2005-10-06 AU AU2005290401A patent/AU2005290401A1/en not_active Abandoned
- 2005-10-06 JP JP2006539359A patent/JP4776544B2/ja active Active
- 2005-10-06 EP EP05793045A patent/EP1811025A4/fr not_active Withdrawn
- 2005-10-06 CA CA002583431A patent/CA2583431A1/fr not_active Abandoned
- 2005-10-06 MX MX2007004149A patent/MX2007004149A/es unknown
- 2005-10-06 ZA ZA200702869A patent/ZA200702869B/xx unknown
- 2005-10-06 RU RU2007116346/13A patent/RU2007116346A/ru unknown
- 2005-10-06 CN CNA2005800369299A patent/CN101052718A/zh active Pending
- 2005-10-06 WO PCT/JP2005/018896 patent/WO2006038729A1/fr active Application Filing
- 2005-10-06 KR KR1020077007975A patent/KR20070100234A/ko not_active Application Discontinuation
-
2007
- 2007-04-10 IL IL182404A patent/IL182404A0/en unknown
- 2007-04-26 NO NO20072158A patent/NO20072158L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
NZ554794A (en) | 2010-01-29 |
CA2583431A1 (fr) | 2006-04-13 |
JPWO2006038729A1 (ja) | 2008-05-15 |
AU2005290401A1 (en) | 2006-04-13 |
US20080063636A1 (en) | 2008-03-13 |
CN101052718A (zh) | 2007-10-10 |
EP1811025A4 (fr) | 2008-02-06 |
RU2007116346A (ru) | 2008-11-20 |
BRPI0516279A (pt) | 2008-09-02 |
EP1811025A1 (fr) | 2007-07-25 |
JP4776544B2 (ja) | 2011-09-21 |
WO2006038729A1 (fr) | 2006-04-13 |
KR20070100234A (ko) | 2007-10-10 |
MX2007004149A (es) | 2007-09-11 |
IL182404A0 (en) | 2007-07-24 |
NO20072158L (no) | 2007-07-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL182404A0 (en) | Mutated amyloid protein | |
GB0514482D0 (en) | Protein | |
GB0417887D0 (en) | Protein | |
GB0401882D0 (en) | Protein | |
GB0416035D0 (en) | Protein | |
GB0405512D0 (en) | Protein | |
GB0401311D0 (en) | Protein | |
GB0422440D0 (en) | Protein | |
GB0400784D0 (en) | Protein | |
GB0405644D0 (en) | Protein | |
GB0400087D0 (en) | Protein | |
GB0427992D0 (en) | Trem-like Protein | |
GB0402662D0 (en) | Protein | |
GB0402811D0 (en) | Protein | |
GB0403742D0 (en) | Protein | |
GB0403979D0 (en) | Protein | |
GB0404929D0 (en) | Protein | |
GB0403142D0 (en) | Protein | |
GB0405057D0 (en) | Protein | |
GB0409950D0 (en) | Protein | |
GB0413407D0 (en) | Protein | |
GB0426962D0 (en) | Protein | |
GB0400783D0 (en) | Protein | |
GB0408217D0 (en) | Protein | |
GB0422058D0 (en) | Protein |